The Tauri-Gum™ Rainbow Deluxe
Sampler Pack
This Innovative New Product Offering
to be Exclusively Available on the Company’s E-Commerce Platform
(www.taurigum.com)
New York, NY -- September 10, 2020 -- InvestorsHub NewsWire --
Tauriga Sciences, Inc. (OTCQB: TAUG)
(“Tauriga” or the “Company”), a revenue generating, diversified
life sciences company, with a proprietary line of functional
“supplement” chewing gums (Flavors: Pomegranate, Blood Orange,
Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two
ongoing Biotechnology initiatives, today confirmed the highly
anticipated upcoming product launch, for its Rainbow Deluxe Sampler
Pack (“Rainbow Pack”). The Rainbow Pack will officially
launch on Sunday, September 20, 2020, exclusively available on the
Company’s E-Commerce platform (www.taurigum.com). The
Company received notification from its contract manufacturer, Per
Os Biosciences, LLC (“Per Os Bio”), that inventory for its
6thTauri-Gum™ flavor, Pear Bellini (“Immune Booster”),
will arrive next week at its E-Commerce fulfillment
facility. There have been substantial levels of interest
in the Rainbow Pack and the pre-sales (which commenced on July 28,
2020) have been very strong. The Company is confident
the launch of its Rainbow Pack will accelerate growth, with respect
to its highest margin E-Commerce business segment.
As of September 10, 2020, the Company has already generated
record Quarterly E-Commerce sales – during this current operating
Quarter (2ndFiscal Quarter 2021).
Pre- Sale(s) Link: Link: https://taurigum.com/products/rainbow-deluxe-sampler-pack
Additionally, the Company is in the final stages of completing a
major Joint Venture Partnership Agreement (“JVP Agreement”) to
enhance both the profile and scale of this upcoming Rainbow Pack
launch. It is anticipated that this JVP Agreement will
be mutually executed within days.
THE COMPLETE Tauri-Gum™ PRODUCT LINE (Rainbow
Pack):
(RAINBOW PACK Contains One Blister Pack of Each Flavor + Special
Decorative Band)
COLOR PRODUCT
DESCRIPTION
1) RED . . . Pomegranate Flavor CBD Infused Tauri-Gum™
2) ORANGE . . . Blood Orange Flavor CBD Infused Tauri-Gum™
3) YELLOW. . . Peach-Lemon Flavor CBG Infused Tauri-Gum™
4) GREEN. . . Pear Bellini Flavor Vitamin C/Zinc Infused
Tauri-Gum™
5) BLUE. . . Mint Flavor CBD Infused Tauri-Gum™
6) PURPLE . . . Black Currant Flavor CBG Infused Tauri-Gum™
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG)
is a revenue generating, diversified life sciences company, engaged
in several major business activities and
initiatives. The company manufactures and distributes
several proprietary retail products and product lines, mainly
focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles
market segment. The main product line, branded as
Tauri-Gum™, consists of a proprietary supplement chewing gum that
is both Kosher certified and Vegan formulated (CBD Infused
Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate) & (CBG
Infused Tauri-Gum™ Flavor: Peach-Lemon). The Company’s
commercialization strategy consists of a broad array of retail
customers, distributors, and a fast-growing E-Commerce business
segment (E-Commerce website: www.taurigum.com). Please visit our
corporate website, for additional information, as well as
inquiries, at http://www.tauriga.com
Complementary to the Company’s retail business, are its two
ongoing biotechnology initiatives. The first one relates
to the development of a Pharmaceutical grade version of Tauri-Gum™,
for nausea regulation (specifically designed to help patients that
are subjected to ongoing chemotherapy treatment). On
March 18, 2020, the Company announced that it filed a provisional
U.S. patent application covering its pharmaceutical grade version
of Tauri-Gum™. The Patent, filed with the U.S.P.T.O. is
Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND
METHODS OF TREATMENT”. The second one relates to a
collaboration agreement with Aegea Biotechnologies Inc. for the
co-development of a rapid, multiplexed, Novel Coronavirus
(COVID-19) test with superior sensitivity and
selectivity.
The Company is headquartered in New York City and operates a
regional office in Barcelona, Spain. In addition, the
Company operates a full time E-Commerce fulfillment center located
in LaGrangeville, New York.
DISCLAIMER -- Forward-Looking Statements
This press release contains certain “forward-looking statements”
as defined by the Private Securities Litigation Reform Act of 1995
which represent management’s beliefs and assumptions concerning
future events. These forward-looking statements are often indicated
by using words such as “may,” “will,” “expects,” “anticipates,”
believes, “hopes,” “believes,” or plans, and may include statements
regarding corporate objectives as well as the attainment of certain
corporate goals and milestones. Forward-looking statements are
based on present circumstances and on management’s present beliefs
with respect to events that have not occurred, that may not occur,
or that may occur with different consequences or timing than those
now assumed or anticipated. Actual results may differ materially
from those expressed in forward looking statements due
to known and unknown risks and uncertainties, such as are not
guarantees of general economic and business conditions, the ability
to successfully develop and market products, consumer and business
consumption habits, the ability to consummate successful
acquisition and licensing transactions, fluctuations in exchange
rates, and other factors over which Tauriga has little or no
control. Many of these risks and uncertainties are discussed in
greater detail in the “Risk Factors” section of Tauriga’s Form 10-K
and other filings made from time to time with the Securities and
Exchange Commission. Such forward-looking statements are made only
as of the date of this release, and Tauriga assumes no obligation
to update forward-looking statements to reflect subsequent events
or circumstances. You should not place undue reliance on these
forward-looking statements.
Contact:
Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY 10022
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Instagram: @taurigum
Twitter: @SethMShaw
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com
Public Relations:
Tiger Global Management
info@TigerGMP.com
www.TigerGMP.com
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Sep 2023 to Sep 2024